Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Oneness Biotech (4743 TT)
Watchlist
20
Analysis
Health Care
•
Taiwan
Oneness Biotech Co Ltd develops botanical new drugs and several biological-active new chemical entities that are purified and molecularly modified from these botanical sources.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Oneness Biotech
•
23 Jul 2024 09:30
Oneness Biotech (4743 TT): Marketing Progress of Fespixon in China Opens a New Revenue Stream
Oneness Biotech partners with CR Double Crane for exclusive commercialization of Fespixon in China, Hong Kong, and Macau. Fespixon is approved in...
Tina Banerjee
Follow
318 Views
Share
bullish
•
Oneness Biotech
•
14 May 2023 23:49
Oneness Biotech (4743 TT): Global Expansion of Marketed Product & Pipeline Progress
Fespixon got approvals for Taiwan and Singapore markets. Bonvadis as a medical device for wound management has been granted market approvals in US,...
Tina Banerjee
Follow
304 Views
Share
bullish
•
Oneness Biotech
•
30 Aug 2022 16:23
Oneness Biotech (4743 TT): Positive Clinical Trial Progress Is Pushing Stock Prices to Higher Highs
Oneness submitted an IND application to the FDA for a phase 1 clinical trial of SNS812 for the treatment of the COVID-19 infection. Fespixon is...
Tina Banerjee
Follow
183 Views
Share
bullish
•
Oneness Biotech
•
19 Mar 2022 18:15
Oneness Biotech (4743 TT): Worth of Attention Ahead of Upcoming Key Milestones
The company’s flagship drug Fespixon has $14 billion global market opportunity, while other late-stage pipeline entail visibility in the long-term....
Tina Banerjee
Follow
368 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.39.3
x